title: [What is new in heart failure with preserved ejection fraction within last five years?].
abstract: Heart failure with preserved ejection fraction of left ventricle (heart failure with normal ejection fraction, HFPEF, HFNEF) is frequent disease with serious consequences. Incidence of HFPEF in population is still growing. The exact pathophysiological mechanism of HFPEF remain unclear .Recent evidence suggests a relationship between inflammation associated with obesity or Diabetes mellitus and progression of HFPEF. Consistently, it has been reported that serum concentration of some pro-inflammatory markers such as adiponectin is positively related to HFPEF. By HFPEF is attended diastolic dysfunction. Diastolic dysfunction is linked to many other cardiac and non-cardiac diseases. Despite the great effort and new therapeutic approaches the prognosis of HFPEF does not improve. The gold standard in HFPEF diagnosis remains heart catheterization. Electrocardiography, chest X-ray, blood examination including diagnostic markers of heart failure and mainly echocardiography with Doppler imaging are used diagnose the underlying disease leading to heart failure.
authors.forename: Zdeňka
authors.initials: Z
authors.lastname: Gregorová
authors.forename: Jaroslav
authors.initials: J
authors.lastname: Meluzín
authors.forename: Lenka
authors.initials: L
authors.lastname: Spinarová
mesh_terms: D015415:Biomarkers; D018450:Disease Progression; D004452:Echocardiography; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000503:physiopathology*; D006801:Humans; D011379:Prognosis; D013318:Stroke Volume; D016277:Ventricular Function, Left
chemical_list: D015415:Biomarkers